Literature DB >> 33681421

Evaluation of CD44 and TGF-B Expression in Oral Carcinogenesis.

Narges Ghazi1, Nasrollah Saghravanian1, Mohammad Taghi Shakeri2, Mounes Jamali3.   

Abstract

STATEMENT OF THE PROBLEM: Oral squamous cell carcinoma (OSCC) is the most common malignancy of the oral cavity. Early diagnosis of OSCC by using biomarkers provides preventive treatment approach to suppress the disease in early stages. CD44 as a cancer stem cell (CSC) marker may be cleaved by MT1-MMP and plays an important role in migration of cancer cells. TGF-B promotes formation of invasive cancer cells phenotype through epithelial mesenchymal transition (EMT) and induces MT1-MMP formation.
PURPOSE: The aim of this study was to evaluate the expression of TGF-B and CD44 in leukoplakia (premalignant lesion), squamous cell carcinoma (SCC), and normal oral mucosa to determine the role of these markers in the carcinogenesis process of the oral mucosa. MATERIALS AND
METHOD: In this retrospective study, the expression of TGF-B and CD44 were evaluated in 55 paraffin-embedded specimens (10normal mucosa, 15 non-dysplastic leukoplakia, 15 dysplastic leukoplakia, and 15 OSCC) by immunohistochemistry. Statistical analyses were performed using Kruskal-Wallis, Mann-Whitney, and Spearman's rank correlation tests.
RESULTS: Evaluation of CD44 and TGF-B expression in the four studied groups showed statistical significant difference for each marker (p< 0.001). Pairwise comparison of CD44 and TGF-B expression in all groups except normal mucosa and non-dysplastic leukoplakia demonstrated statistical significant difference. In addition, there was positive significant correlation between two markers (r= 0.914, p< 0.001). Diagnostic test's accuracy for identification of OSCC and dysplastic leukoplakia from non-dysplastic leukoplakia and normal tissues and recognition of OSCC from dysplastic leukoplakia showed optimum sensitivity and specificity.
CONCLUSION: Increased expression of CD44 as a cancer stem cell marker and TGF-B as an EMT marker from normal mucosa to non-dysplastic leukoplakia, dysplastic leukoplakia, and OSCC and also the significant correlation between these two markers indicated their role in carcinogenesis of oral mucosa. Copyright: © Journal of Dentistry.

Entities:  

Keywords:  CD44; Dysplasia; Oral squamous cell carcinoma; TGF-B

Year:  2021        PMID: 33681421      PMCID: PMC7921764          DOI: 10.30476/DENTJODS.2020.84393.1079

Source DB:  PubMed          Journal:  J Dent (Shiraz)        ISSN: 2345-6418


  32 in total

1.  Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells.

Authors:  Michael F Clarke; John E Dick; Peter B Dirks; Connie J Eaves; Catriona H M Jamieson; D Leanne Jones; Jane Visvader; Irving L Weissman; Geoffrey M Wahl
Journal:  Cancer Res       Date:  2006-09-21       Impact factor: 12.701

2.  CD44+/CD133+ immunophenotype and matrix metalloproteinase-9: Influence on prognosis in early-stage oral squamous cell carcinoma.

Authors:  Lucinei R Oliveira; Andrielle Castilho-Fernandes; João Paulo Oliveira-Costa; Fernando A Soares; Sérgio Zucoloto; Alfredo Ribeiro-Silva
Journal:  Head Neck       Date:  2014-01-29       Impact factor: 3.147

3.  CD44 variant 6 (CD44v6) expression as a progression marker in benign, premalignant and malignant oral epithelial tissues.

Authors:  R Bahar; M Kunishi; Y Kayada; K Yoshiga
Journal:  Int J Oral Maxillofac Surg       Date:  1997-12       Impact factor: 2.789

4.  Synergistic effects of CD44 and TGF-β1 through AKT/GSK-3β/β-catenin signaling during epithelial-mesenchymal transition in liver cancer cells.

Authors:  Na Ri Park; Jung Hoon Cha; Jeong Won Jang; Si Hyun Bae; Bohyun Jang; Jung-Hee Kim; Wonhee Hur; Jong Young Choi; Seung Kew Yoon
Journal:  Biochem Biophys Res Commun       Date:  2016-06-16       Impact factor: 3.575

5.  Aberrant expression of Smad4, a TGF-beta signaling molecule, in oral squamous cell carcinoma.

Authors:  Anak Iamaroon; Kassara Pattamapun; Siribang-On Piboonniyom
Journal:  J Oral Sci       Date:  2006-09       Impact factor: 1.556

Review 6.  The cancer stem cell: premises, promises and challenges.

Authors:  Hans Clevers
Journal:  Nat Med       Date:  2011-03       Impact factor: 53.440

7.  CD44 expression in dysplastic epithelium and squamous-cell carcinoma of the esophagus.

Authors:  G D Roye; R B Myers; D Brown; R Poczatek; S W Beenken; W E Grizzle
Journal:  Int J Cancer       Date:  1996-08-22       Impact factor: 7.396

8.  Expression of the cell adhesion molecule CD44 in gastric adenocarcinomas.

Authors:  K Washington; M R Gottfried; M J Telen
Journal:  Hum Pathol       Date:  1994-10       Impact factor: 3.466

9.  TRAF6 regulates tumour metastasis through EMT and CSC phenotypes in head and neck squamous cell carcinoma.

Authors:  Lei Chen; Yi-Cun Li; Lei Wu; Guang-Tao Yu; Wen-Feng Zhang; Cong-Fa Huang; Zhi-Jun Sun
Journal:  J Cell Mol Med       Date:  2017-11-29       Impact factor: 5.310

Review 10.  The biology and role of CD44 in cancer progression: therapeutic implications.

Authors:  Chen Chen; Shujie Zhao; Anand Karnad; James W Freeman
Journal:  J Hematol Oncol       Date:  2018-05-10       Impact factor: 17.388

View more
  2 in total

1.  MT1-MMP Cooperates with TGF-β Receptor-Mediated Signaling to Trigger SNAIL and Induce Epithelial-to-Mesenchymal-like Transition in U87 Glioblastoma Cells.

Authors:  Souad Djediai; Narjara Gonzalez Suarez; Layal El Cheikh-Hussein; Sahily Rodriguez Torres; Loraine Gresseau; Sheraz Dhayne; Zoé Joly-Lopez; Borhane Annabi
Journal:  Int J Mol Sci       Date:  2021-11-30       Impact factor: 5.923

2.  Differential immunohistochemical expression of DEC1, CK‑1ε, and CD44 in oral atypical squamous epithelium and carcinoma in situ.

Authors:  Fuyuki Sato; Ujjal K Bhawal; Shoko Osaki; Nao Sugiyama; Kosuke Oikawa; Yasuteru Muragaki
Journal:  Mol Med Rep       Date:  2022-03-10       Impact factor: 2.952

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.